CoChat

Effects of Extended-Release Nicotinic Acid on Apolipoprotein (a) Kinetics in Hypertriglyceridemic Patients

Croyal, Mikaël, Ouguerram, Khadija, Passard, Maxime, Ferchaud-Roucher, Véronique, Chétiveaux, Maud, Billon-Crossouard, Stéphanie, de Gouville, Anne-Charlotte, Lambert, Gilles, Krempf, Michel, Nobécourt, Estelle · 2015 · Arteriosclerosis, Thrombosis, and Vascular Biology
Cited by 62

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Objective—: To determine the mechanisms by which extended-release nicotinic acid reduces circulating lipoprotein (a) concentrations in hypertriglyceridemic patients. Approach and Results—: Eight nondiabetic, obese male subjects (aged 48±12 years; body mass index, 31.2±1.8 kg/m 2 ) with hypertriglyceridemia (triglycerides, 226±78 mg/dL) were enrolled in an 8 week, double blind, placebo-controlled cross-over study. At the end of each treatment phase, fasted subjects received a 10 µmol/L per kg bolus injection of [5,5,5- 2 H 3 ]- l -Leucine immediately followed by constant infusion of [5,5,5- 2 H 3 ]- l -Leucine (10 µmol L −1 kg −1 h −1 ) for 14 hours, and blood samples were collected. A liquid chromatography–tandem mass spectrometry method was used to study apolipoprotein (a) (Apo(a)) kinetics. The fractional catabolic rate of Apo(a) was calculated with a single compartmental model using the apolipoprotein B100 (ApoB100) containing very low density lipoprotein tracer enrichment as a precursor pool. Extended-release nicotinic acid decreased plasma triglycerides (−46%; P =0.023), raised high-density lipoprotein cholesterol (+20%; P =0.008), and decreased Apo(a) plasma concentrations (−20%; P =0.008). Extended-release nicotinic acid also decreased ApoB100 (22%; P =0.008) and proprotein convertase subtilisin/kexin type 9 (PCSK9, −29%; P =0.008) plasma concentrations. Apo(a) fractional catabolic rate and production rates were decreased by 37% (0.58±0.28 versus 0.36±0.19 pool/d; P =0.008) and 50% (1.4±0.8 versus 0.7±0.4 nmol/kg per day; P =0.008), respectively. Conclusions—: Extended-release nicotinic acid treatment decreased Apo(a) plasma concentrations by 20%, production rates by 50%, and catabolism by 37%. ApoB100 and PCSK9 concentrations were also decreased by treatment, but no correlation was found with Apo(a) kinetic parameters.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/atvbaha.115.305835

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 62

Metadata

Authors
Croyal, M., Ouguerram, K., Passard, M., Ferchaud-Roucher, V., Chétiveaux, M., Billon-Crossouard, S., de Gouville, A.-C., Lambert, G., Krempf, M., & Nobécourt, E.
Venue
Arteriosclerosis, Thrombosis, and Vascular Biology
Published
2015-09
Volume
35
Issue
9
Pages
2042-2047
ISSN
  • 1079-5642 (ISSN-L)
  • 1524-4636
OpenAlex
W2120640025
Cited by
62
References
10
FWCI
7.57
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of Extended-Release Nicotinic Acid on Apolipoprotein (a) Kinetics in Hypertriglyceridemic Patients. https://app.cochat.ai/papers/10.1161/atvbaha.115.305835
The paper
Croyal, M., Ouguerram, K., Passard, M., Ferchaud-Roucher, V., Chétiveaux, M., Billon-Crossouard, S., de Gouville, A.-C., Lambert, G., Krempf, M., & Nobécourt, E. (2015). Effects of Extended-Release Nicotinic Acid on Apolipoprotein (a) Kinetics in Hypertriglyceridemic Patients. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.115.305835

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.